More Langsing, Elon Musk Admits Consumption Of Anti-Obesity Drugs To Lose Weight

Elon Musk. (Doc. Instagram/@elonmusk_official_)

JAKARTA - Elon Musk, CEO of Tesla and SpaceX, is now looking slimmer. Recently he revealed that he was taking a weight loss drug known as Mounjaro.

This disclosure was discovered after Musk showed his support for the use of similar drugs as a solution to overcome obesity, which is now the main health problem in the United States.

In a post on social media, Musk shared a photo of himself wearing a Santa Claus costume complete with a long white beard. He calls himself Ozempic Santa, although later clarifying that the drugs he consumes are Mounjaro, not Ozempic, although both belong to the same class of drugs.

"Like the Cocaine Bear, but Santa and Ozempic !," Musk wrote on his personal X account, adding that Mounjaro was more in line with his needs than Ozempic did because side effects were milder.

"Technically, Mounjaro, but it doesn't sound that seatractive," he continued.

Reported by VOI from the New York Post page on Saturday, December 28, 2024, Mounjaro, such as Ozempic, is an obstacle to GLP-1, a type of drug developed to help diabetics regulate their blood glucose and insulin levels. However, more and more Americans use the GLP-1 inhibition to successfully lose weight.

This 53-year-old man revealed that he prefers Mounjaro over Ozempic. Because Ozempic has side effects, such as frequent farts and sendawas.

"Mounjaro appears to have fewer and more effective side effects," said the man who now serves as Department of Government Efficiency under President-elect Donald Trump.

Musk has long advocated the widespread use of GLP-1 inhibitors to address obesity, a view that goes against the attitude of the appointed US Secretary of Health and Human Services, Robert F. Kennedy Jr., on this drug.

Kennedy argues that it's best to encourage Americans to eat healthier. This will be a more effective and cost-effective way of dealing with the obesity crisis.

Musk's support for the GLP-1 inhibition received praise from the hosts of "The View", one of which wasmintapi Goldberg, who also admitted to consuming Mounjaro.

"Elon is right in this regard," Goldberg said in a discussion earlier this month about the different views between Musk and the US Secretary of Health and Human Services.

Later, he showed his slimmer body after revealing to the audience that his weight was almost 300 pounds two years ago before he started consuming Mounjaro.

Musk, who previously admitted that he did not like sports, has also revealed that he had taken the drug of Wegovy obesity, another GLP-1 inhibitor in 2022.